Q3 2024 |
12 |
$315M |
+$14.4M |
-$152M |
-$137M |
LQDA, VRNA, EXEL, EOLS, ANIK
|
13F-HR |
11/14/2024, 05:15 PM |
Q2 2024 |
13 |
$428M |
+$61M |
-$62.8K |
+$60.9M |
LQDA, ALIM, ANIK, EXEL, BCRX
|
13F-HR |
8/14/2024, 03:57 PM |
Q1 2024 |
12 |
$378M |
+$66.9M |
-$25.8M |
+$41.1M |
LQDA, ALIM, ANIK, EOLS, EXEL
|
13F-HR |
5/13/2024, 04:10 PM |
Q4 2023 |
11 |
$297M |
+$30.2M |
-$6.71M |
+$23.5M |
LQDA, ALIM, ANIK, EXEL, LAB
|
13F-HR |
2/14/2024, 02:36 PM |
Q3 2023 |
12 |
$196M |
+$58.9M |
-$21.1M |
+$37.8M |
LQDA, ALIM, LAB, ANIK, EXEL
|
13F-HR |
11/14/2023, 08:39 AM |
Q2 2023 |
12 |
$165M |
+$17.3M |
-$4.31M |
+$13M |
LQDA, ANIK, EXEL, LAB, ICPT
|
13F-HR |
8/14/2023, 05:17 PM |
Q1 2023 |
11 |
$143M |
+$20M |
-$5.98M |
+$14.1M |
LQDA, ANIK, LAB, EXEL, EOLS
|
13F-HR |
5/15/2023, 08:46 AM |
Q4 2022 |
11 |
$120M |
$0 |
$0 |
|
LQDA, ANIK, EOLS, ADMA, LAB
|
Restatement |
5/15/2023, 09:34 AM |